Skip to main content
Caplight Logo









Spaero Bio

Spaero Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://spaero.bio/

Last Round

Seed

Jul 31, 2024

Total Funding Raised

$4M

Company Overview

Spaero Bio is a business and productivity software company that develops a robot-agnostic software system designed to automate biological experiments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Workflow Automation, Biotech Equipment

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

lab automationliquid handlingrobot-agnostic softwarebiotech automationcomputer visionlab opsexperimental workflowmachine learningR&D automationliquidQClab roboticsSaaSbio-automationprotocol automationlab-in-the-loop

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spaero Bio Comparables

Compare Spaero Bio with similar companies based on industry and business-model similarity.

Spaero Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Synthace
78%
Labforward
69%
Axel Johnson Inc.
69%

Spaero Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 31, 2024
SeedJan 31, 2024
AcceleratorMar 22, 2022

Key People

Founding team and executive leadership

Mitch Adler

Founder CEO

Founding Team

Spaero Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 31, 2024

    $2M round led by Cantos Ventures and The Compound Capital Fund.

  • Mar 22, 2022

    REVOLUTION Turbine Technologies led the round.

Spaero Bio Filings

Explore SEC and related filing metadata, where available.

Spaero Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spaero Bio's valuation, stock price, and market status.

Is Spaero Bio a public or private company?

Spaero Bio is a private company.

What is the current stock price of Spaero Bio?

Spaero Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Spaero Bio worth (valuation)?

Valuation information for Spaero Bio is not publicly available.

Can I buy Spaero Bio stock?

Spaero Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spaero Bio's last funding round?

Spaero Bio's most recent funding round was Seed on July 31, 2024.

Who are the main investors in Spaero Bio?

Key investors in Spaero Bio include AlleyCorp, BlueYard Capital, Cantos Ventures, Acequia Capital, AIX Ventures.

Will Spaero Bio IPO soon?

No public IPO plans have been announced for Spaero Bio.

How can I track Spaero Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spaero Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range1
Year Founded2020
Last FundingJul 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?